ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma.

Zhen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.